Area of research
Electrical and Electronic Engineering · Materials Chemistry
Research interest
Research focused on Cancer research and Tumor microenvironment, with related work in Phosphorylation, Chronotherapy (sleep phase), Gene. Notable publications include 'Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy', 'The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer', and 'The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy'.
Synergistic heterogeneous catalysis: MoS2/α-FeOOH nanocomposites for pH-universal PMS activation and efficient antibiotic degradation
Multi-modal luminescence in rare earth-doped double perovskite oxides and highly thermal sensitivity from coupled energy levels
Engineered Energy Transfer in Room Temperature Phosphorescent Materials for Time‐Resolved Dual‐Mode Encryption
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
Highly Effective Hybrid Copper(I) Iodide Cluster Emitter with Negative Thermal Quenched Phosphorescence for X‐Ray Imaging
Two triplet emitting states in one emitter: Near-infrared dual-phosphorescent Au <sub>20</sub> nanocluster
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis
Simultaneous manipulation of scalable absorbance and the electronic bridge for efficient CO<sub>2</sub> photoreduction
Water Resistance and Flexible Cuprous Halide Composite Polysiloxane Luminescent Ceramics
Efficient energy transfer in Cs<sub>4</sub>Mn<sub><i>x</i></sub>Cd<sub>1−<i>x</i></sub>Sb<sub>2</sub>Cl<sub>12</sub> layered perovskites and anomalously responsive photodetectors
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy
X-ray scintillation in lead-free double perovskite crystals
Expression of Long Noncoding RNA <i>YIYA</i> Promotes Glycolysis in Breast Cancer
A ROR1–HER3–lncRNA signalling axis modulates the Hippo–YAP pathway to regulate bone metastasis
The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer